173 related articles for article (PubMed ID: 26862924)
1. INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS.
Seidman CJ; Finger PT; Silverman JS; Oratz R
Retin Cases Brief Rep; 2017 Winter; 11(1):47-50. PubMed ID: 26862924
[TBL] [Abstract][Full Text] [Related]
2. Use of Intravitreal Bevacizumab for the Treatment of Secondary Glaucoma Caused by Metastatic Iris Tumor.
Aydin R; Tezel TH
J Glaucoma; 2018 Jun; 27(6):e113-e116. PubMed ID: 29613980
[TBL] [Abstract][Full Text] [Related]
3. MANAGEMENT OF METASTATIC BREAST CARCINOMA OF IRIS WITH INTRAOCULAR BEVACIZUMAB INJECTIONS.
Akinci GE; Hondur AM; Tezel TH
Retin Cases Brief Rep; 2019 Summer; 13(3):220-223. PubMed ID: 28346258
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
Ishibashi S; Kondo H
J UOEH; 2015 Dec; 37(4):299-304. PubMed ID: 26667197
[TBL] [Abstract][Full Text] [Related]
6. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma.
Vale S; Montalvo L; Baez E; Oliver AL
Am J Ophthalmol Case Rep; 2018 Mar; 9():45-47. PubMed ID: 29468218
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
Lupinacci AP; Calzada JI; Rafieetery M; Charles S; Netland PA
Adv Ther; 2009 Feb; 26(2):208-16. PubMed ID: 19234680
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung.
Yokouchi H; Kitahashi M; Oshitari T; Yamamoto S
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2243-5. PubMed ID: 23250479
[No Abstract] [Full Text] [Related]
11. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
[TBL] [Abstract][Full Text] [Related]
12. [Use of bevacizumab as an additional strategy in angle closure glaucoma--case report].
Helemejko I; Jurowska-Liput J
Klin Oczna; 2010; 112(1-3):61-2. PubMed ID: 20572507
[TBL] [Abstract][Full Text] [Related]
13. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated With Refractory Secondary Glaucoma.
Makri OE; Psachoulia C; Exarchou A; Georgakopoulos CD
J Glaucoma; 2016 Jan; 25(1):e53-5. PubMed ID: 25304284
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma.
Yeung SN; Paton KE; Waite C; Maberley DA
Can J Ophthalmol; 2010 Jun; 45(3):269-73. PubMed ID: 20379286
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
Chilov MN; Grigg JR; Playfair TJ
Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization.
Ababneh OH; Yousef YA; Gharaibeh AM; Abu Ameerh MA; Abu-Yaghi NE; Al Bdour MD
Retina; 2013 Apr; 33(4):748-55. PubMed ID: 23296048
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
Nakashima C; Keino H; Watanabe T; Taki W; Okada AA
Jpn J Ophthalmol; 2011 Jan; 55(1):80-1. PubMed ID: 21331703
[No Abstract] [Full Text] [Related]
19. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
Sothornwit N
J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
